0001140361-18-028232.txt : 20180612 0001140361-18-028232.hdr.sgml : 20180612 20180612162856 ACCESSION NUMBER: 0001140361-18-028232 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180611 FILED AS OF DATE: 20180612 DATE AS OF CHANGE: 20180612 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: JOULWAN GEORGE A CENTRAL INDEX KEY: 0001222197 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33137 FILM NUMBER: 18894764 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Emergent BioSolutions Inc. CENTRAL INDEX KEY: 0001367644 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 141902018 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 400 PROFESSIONAL DR, SUITE 400 CITY: GAITHERSBURG STATE: MD ZIP: 20879 BUSINESS PHONE: 240-631-3200 MAIL ADDRESS: STREET 1: 400 PROFESSIONAL DR, SUITE 400 CITY: GAITHERSBURG STATE: MD ZIP: 20879 4 1 doc1.xml FORM 4 X0306 4 2018-06-11 0 0001367644 Emergent BioSolutions Inc. EBS 0001222197 JOULWAN GEORGE A 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879 1 0 0 0 Common Stock 2018-06-11 4 S 0 5000 52.8895 D 30272 D The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.73 to $53.125, inclusive. /s/ S. Scott Lieberman, Attorney-in-fact 2018-06-12